Pages that link to "Q53174548"
Jump to navigation
Jump to search
The following pages link to B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL). (Q53174548):
Displaying 4 items.
- Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma? (Q39294879) (← links)
- Identification of a tumor suppressor network in T-cell leukemia. (Q53536725) (← links)
- Diagnosis of Hodgkin lymphoma in the modern era (Q58577077) (← links)
- Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies (Q89940657) (← links)